galactosyl-1,3-n-acetylglucosamine and Breast Neoplasms

galactosyl-1,3-n-acetylglucosamine has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bovin, NV; Fodstad, O; Høifødt, HK; Kierulf, B; Rye, PD; Trones, GE; Vlasova, E	1

Other Studies

1 other study(ies) available for galactosyl-1,3-n-acetylglucosamine and Breast Neoplasms

Article	Year
Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure. Biochemical Society transactions, 1995, Volume: 23, Issue:4 Topics: Acetylglucosamine; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Body Fluids; Breast Neoplasms; Female; Humans; Immunomagnetic Separation	1995

Article

Year

Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure.

Biochemical Society transactions, 1995, Volume: 23, Issue:4

Topics: Acetylglucosamine; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Body Fluids; Breast Neoplasms; Female; Humans; Immunomagnetic Separation

1995